Skip to main content
Raymond Hohl, MD, Oncology, Hershey, PA, Penn State Milton S. Hershey Medical Center

RaymondJHohlMD

Oncology Hershey, PA

Director, Penn State Cancer Insititute Professor of Medicine and Pharmacology, Penn State University

Dr. Hohl is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Hohl's full profile

Already have an account?

Education & Training

  • University of Chicago
    University of ChicagoFellowship, Hematology and Medical Oncology, 1989 - 1991
  • University of Chicago
    University of ChicagoFellowship, Hematology and Medical Oncology, 1987 - 1989
  • University of Chicago
    University of ChicagoResidency, Internal Medicine, 1984 - 1987
  • Rush Medical College of Rush University Medical Center
    Rush Medical College of Rush University Medical CenterClass of 1984

Certifications & Licensure

  • PA State Medical License
    PA State Medical License 2014 - 2024
  • IA State Medical License
    IA State Medical License 1991 - 2014
  • IL State Medical License
    IL State Medical License 1984 - 2011
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • Regional Top Doctor Castle Connolly, 2014
  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Inhibiting Geranylgeranyl Diphosphate Synthesis Reduces Nuclear Androgen Receptor Signaling and Neuroendocrine Differentiation in Prostate Cancer Cell Models  
    Raymond Hohl, MD, The Prostate

Press Mentions

  • Machtay Named Cancer Institute Associate Director for Clinical Research
    Machtay Named Cancer Institute Associate Director for Clinical ResearchSeptember 29th, 2020
  • Penn State Cancer Institute Joins Caris Life Sciences' Precision Oncology Alliance
    Penn State Cancer Institute Joins Caris Life Sciences' Precision Oncology AllianceAugust 25th, 2020
  • Hershey Medical Center Names New Radiation Oncology Chair
    Hershey Medical Center Names New Radiation Oncology ChairMarch 7th, 2019
  • Join now to see all

Grant Support

  • Career Development ProgramNational Cancer Institute2007–2011
  • Cell Signaling And Developmental PharmacologyNational Cancer Institute2009
  • Cell SignalingNational Cancer Institute2005
  • Core--Analytical Pharmacology LaboratoryNational Cancer Institute2003
  • Trial Of Irinotecan In PTS With Abnormal Liver/Renal Function Or Prior Pelvic RADNational Center For Research Resources2000–2002
  • Phase I Trial Of Perillyl Alcohol AdminstrationNational Center For Research Resources1998–2000
  • Phase I Study Of Taxol For Patients With Primary Or Metastatic Liver TumorsNational Center For Research Resources1996
  • High Dose Lovastatin For Treatment Of RAS Oncogene Associated MalignanciesNational Center For Research Resources1996

Professional Memberships

Hospital Affiliations